Vitae
Allergan snaps up Vitae Pharma for $639 million
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition
Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …
Novartis’ Christine Brennan joins Vitae
July 26, 2010Sales and Marketing Vitae, appointment, sales and marketing
US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. She has over 10 years industry experience and …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
